Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Protara Therapeutics Inc. TARA

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).


Recent & Breaking News (NDAQ:TARA)

Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference

GlobeNewswire October 25, 2016

Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors

GlobeNewswire October 20, 2016

HC Wainwright Bullish On Proteon Therapeutics, Sees 105% Potential Upside

Benzinga.com  September 22, 2016

Proteon Therapeutics to Present at Two Upcoming Investor Conferences

GlobeNewswire September 1, 2016

Proteon Therapeutics Announces Second Quarter 2016 Financial Results

GlobeNewswire August 8, 2016

Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd

GlobeNewswire June 15, 2016

Proteon Therapeutics Announces First Quarter 2016 Financial Results

GlobeNewswire May 9, 2016

Proteon Therapeutics Announces Survey Findings Demonstrating Impact of Vascular Access Failure on Hemodialysis Patients

GlobeNewswire April 28, 2016

Proteon Therapeutics Announces Publication in the Journal of Cardiovascular Pharmacology of Promising Nonclinical Results for Vonapanitase in Peripheral Artery Disease

GlobeNewswire April 13, 2016

Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results

GlobeNewswire March 14, 2016

Proteon Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference on March 8th

GlobeNewswire March 2, 2016

Proteon Therapeutics to Present at the 2016 BIO CEO & Investor Conference February 8th

GlobeNewswire February 2, 2016

How it all Plays Out - Research on Lawson Products, PAM Transportation Services, Hallmark Financial Services and Proteon Therapeutics

Accesswire December 7, 2015

Proteon Therapeutics to Present at the Oppenheimer 26th Annual Healthcare Conference December 9th

GlobeNewswire December 2, 2015

Trading Ahead of Upcoming Developments - Research on Lawson Products, PAM Transportation Services, Hallmark Financial Services and Proteon Therapeutics

Accesswire November 27, 2015

Proteon Therapeutics to Present at the Stifel 2015 Healthcare Conference on November 17th

GlobeNewswire November 13, 2015

Proteon Therapeutics Announces Third Quarter 2015 Financial Results

GlobeNewswire November 12, 2015

Proteon Therapeutics to Host Research and Development Day on November 20, 2015

GlobeNewswire November 9, 2015

Proteon Therapeutics Completes Enrollment in PATENCY-1, First Phase 3 Clinical Study of Investigational Vonapanitase

GlobeNewswire November 2, 2015

Proteon Therapeutics to Present at the BIO-Europe 2015 Conference November 3

GlobeNewswire October 28, 2015